Assessing Anticoagulation Therapy Management Services

评估抗凝治疗管理服务

• 批准号: 7111354
• 负责人: Danielle M Chauncey-Lavallee
• 金额: $ 5.21万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-02-01 至 2008-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7111354
• 关键词: behavioral /social science research tag; belief; blood coagulation; cardiovascular disorder risk; clinical research; clinical trials; decision making; drug adverse effect; education evaluation /planning; health behavior; health care service evaluation; health education; health services research tag; human subject; outcomes research; patient care management; patient care personnel relations; patient care planning; patient oriented research; patient safety /medical error; pharmacy; predoctoral investigator; therapy compliance; warfarin

DESCRIPTION (provided by the applicant): The long-term goal of this research is to improve health outcomes in patients on chronic oral anticoagulation therapy. My primary aim is to determine the impact on INR control resulting from the integration of information on patient health literacy and numeracy, health knowledge and health beliefs regarding warfarin therapy into the clinical information provided to the pharmacist. The central hypothesis of this research is that by expanding the clinical information available to incorporate information pertaining to patients' health literacy and numeracy, health knowledge and health beliefs, clinicians will be able to tailor educational interventions and decision-making to best fit the patients' needs. To test the central hypothesis, the proposed study will address the following three aims: (1) To determine if patient health knowledge, health beliefs, and health literacy and numeracy of warfarin therapy, when integrated into pharmacists' clinical information, will impact patients INR control. (2) To determine if patient health knowledge, health beliefs, and health literacy and numeracy of warfarin, when integrated into pharmacists' clinical information, will impact patient's knowledge of oral anticoagulation therapy. (3) To determine the cost implications resulting from the additional process of collecting, analyzing and incorporating information on patient health knowledge, health beliefs, and health literacy and numeracy regarding warfarin therapy.

描述（由申请人提供）：本研究的长期目标是改善慢性口服抗凝治疗患者的健康结果。我的主要目的是确定将患者健康素养和计算能力、有关华法林治疗的健康知识和健康信念的信息整合到提供给药剂师的临床信息中对INR控制的影响。本研究的中心假设是，通过扩大可用的临床信息，将有关患者健康素养和算术、健康知识和健康信念的信息纳入其中，临床医生将能够定制教育干预和决策，以最适合患者的需求。为了验证中心假设，本研究将解决以下三个问题：(1)确定患者的健康知识、健康信念、华法林治疗的健康素养和计算能力，当整合到药剂师的临床信息中时，是否会影响患者的INR控制。(2)确定纳入药师临床信息后，患者的健康知识、健康信念、华法林的健康素养和计算能力是否会影响患者对口服抗凝治疗的认识。(3)确定收集、分析和纳入有关华法林治疗的患者健康知识、健康信念以及健康素养和计算能力的信息的额外过程所涉费用。